These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24084666)

  • 1. [Revolution in interventional cardiology: the fully bioresorbable vascular scaffold. Presentation].
    Bolognese L
    G Ital Cardiol (Rome); 2013 Sep; 14(9 Suppl 1):3S. PubMed ID: 24084666
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure and function of the fully bioresorbable vascular scaffold].
    De Servi S
    G Ital Cardiol (Rome); 2013 Sep; 14(9 Suppl 1):4S-7S. PubMed ID: 24084667
    [No Abstract]   [Full Text] [Related]  

  • 3. [Who is the ideal patient for treatment with the Absorb™ bioresorbable vascular scaffold?].
    Indolfi C
    G Ital Cardiol (Rome); 2013 Sep; 14(9 Suppl 1):12S-14S. PubMed ID: 24084669
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioresorbable scaffolds: talking about a new interventional revolution [corrected].
    Hassell ME; Grundeken MJ; Delewi R; Wykrzykowska JJ; Piek JJ
    Minerva Cardioangiol; 2013 Apr; 61(2):165-79. PubMed ID: 23492600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy.
    Wykrzykowska JJ; Onuma Y; Serruys PW
    EuroIntervention; 2009 Dec; 5 Suppl F():F7-8. PubMed ID: 22100680
    [No Abstract]   [Full Text] [Related]  

  • 6. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary spasm revascularized with a bioresorbable vascular scaffold.
    Bil J; Pawlowski T; Gil RJ
    Coron Artery Dis; 2015 Nov; 26(7):634-6. PubMed ID: 26267749
    [No Abstract]   [Full Text] [Related]  

  • 8. Design principles and performance of bioresorbable polymeric vascular scaffolds.
    Oberhauser JP; Hossainy S; Rapoza RJ
    EuroIntervention; 2009 Dec; 5 Suppl F():F15-22. PubMed ID: 22100671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BVS concept. From the chemical structure to the vascular biology: the bases for a change in interventional cardiology.
    Tarantini G; Masiero G; Granada JF; Rapoza RJ
    Minerva Cardioangiol; 2016 Aug; 64(4):419-41. PubMed ID: 27078631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First ad hoc bioresorbable vascular scaffold bench test: a glimpse into percutaneous bifurcation interventions.
    Sgueglia GA; D'Errico F; Gioffrè G; De Santis A; Gaspardone A
    Int J Cardiol; 2014 Apr; 172(3):604-6. PubMed ID: 24491860
    [No Abstract]   [Full Text] [Related]  

  • 11. Looking into the future with bioresorbable vascular scaffolds.
    Costopoulos C; Naganuma T; Latib A; Colombo A
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1407-16. PubMed ID: 24138526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.
    Ielasi A; Tespili M
    Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for the use of bioresorbable vascular scaffolds. Why bioresorbable technology is the future of endovascular therapeutics.
    Ribichini F
    Minerva Cardioangiol; 2016 Aug; 64(4):399-403. PubMed ID: 27228487
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trials evaluating the Absorb bioresorbable vascular scaffold].
    Bartorelli AL
    G Ital Cardiol (Rome); 2013 Sep; 14(9 Suppl 1):8S-11S. PubMed ID: 24084668
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioresorbable Vascular Scaffolds in Coronary Bifurcation Lesions: Only in Expert Hands.
    Colleran R; Byrne RA
    Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):543-6. PubMed ID: 27157886
    [No Abstract]   [Full Text] [Related]  

  • 16. Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment.
    García-García HM; Schultz C; Duckers E; Regar E; Ligthart J; Serruys PW; van Geuns RJ
    EuroIntervention; 2013 Feb; 8(10):1126-7. PubMed ID: 23014900
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioresorbable scaffolds: the fee comes now and the reward comes later.
    Jabbour RJ; Colombo A
    Future Cardiol; 2016 Jul; 12(4):397-400. PubMed ID: 27291396
    [No Abstract]   [Full Text] [Related]  

  • 18. Regeneration of vessel wall functionality and vascular restoration therapy with biodegradable stents -- current status.
    Depukat R; Rzeszutko L; Dudek D
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2440-8. PubMed ID: 22280418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The bioresorbable coronary scaffold].
    Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
    Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioresorbable vascular scaffolds: implication of very late scaffold thrombosis.
    Mori H; Virmani R; Finn AV
    Coron Artery Dis; 2017 Nov; 28(7):533-538. PubMed ID: 28692483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.